Gateway 2012: I Holland Limited - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: I Holland Limited



Your online Gateway to I Holland Limited in 2012

Meadow Lane, Long Eaton,
Nottingham, NG10 2GD, England
Telephone:+44 (0) 115 972 6153
Fax: +44 (0) 115 973 1789
www.iholland.co.uk

I Holland Americas
1684 Target Court, Suite 3
Fort Myers, FL 33905
web: www.iholland-americas.com
Telephone: 1-800-420-2991
Email: ihollandtools@comcast.net

About I Holland Limited

More than six decades of research, development and investment has established I Holland as the leading supplier of punches and dies to producers of tablets in a variety of sectors.



Our Commitment to understanding the science behind tabletting has led to the development of innovative materials, bespoke tablet/tool design and established quality assurance technology, all supported by unrivalled customer service.

I Holland is now the sole distributor of OTEC DF (Drag Finishing) machines and consumables in North America.

The automated polisher is just one part of our PharmaCare™ 7-Step Process, developed as a professional maintenance and storage program for punches & dies, enabling you to get the most out of your investment and increase your productivity.

See demonstrations of our PharmaCare™ equipment at Interphex booth#3532 or our newly opened Technical Support Center in Fort Myers, Florida.

New Products
and Releases
New Whitepapers

iHolland Tablet Tooling

Case Study ‘Pfizer Anti-Stick Trials
I Holland Multi Tip Tooling Research Document ‘Atomic Force Microscopy Anti-Sticking Research’
I Holland PharmaCareTM 7-Step Process  

 

 

For more information:

info@iholland.co.uk

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here